US 12,485,092 B2
Composition for promoting drug release of drug-delivery liposomes
Soo Jeong Lim, Seoul (KR); Eun A Kim, Gyeonggi-do (KR); So Hee Kim, Seoul (KR); and Hyeon Gyeom Choi, Gyeonggi-do (KR)
Assigned to INDUSTRY ACADEMY COOPERATION FOUNDATION OF SEJONG UNIVERSITY, Seoul (KR); and AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, Gyeonggi-Do (KR)
Filed by INDUSTRY ACADEMY COOPERATION FOUNDATION OF SEJONG UNIVERSITY, Seoul (KR); and AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, Gyeonggi-do (KR)
Filed on Mar. 16, 2023, as Appl. No. 18/122,284.
Claims priority of application No. 10-2022-0032877 (KR), filed on Mar. 16, 2022; and application No. 10-2023-0020822 (KR), filed on Feb. 16, 2023.
Prior Publication US 2023/0301911 A1, Sep. 28, 2023
Int. Cl. A61K 9/127 (2025.01); A61K 9/1271 (2025.01); A61K 9/1277 (2025.01); A61K 31/704 (2006.01); A61P 35/00 (2006.01)
CPC A61K 9/127 (2013.01) [A61K 9/1271 (2013.01); A61K 9/1277 (2013.01); A61K 31/704 (2013.01); A61P 35/00 (2018.01)] 13 Claims
 
1. A composition for delivering a drug, comprising
a membrane-modified liposome formed by bringing a liposome carrying a drug into contact with an empty liposome not carrying the drug,
wherein empty liposome comprises a membrane comprised of phospholipid having a head and two fatty acid chains, wherein both of the two fatty acid chains comprises omega-3 fatty acids or their derivatives.